Published in J Clin Endocrinol Metab on September 01, 1995
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97
Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care (2011) 1.25
Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci U S A (2009) 1.01
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique. Clin Exp Immunol (2006) 0.98
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J Clin Endocrinol Metab (2009) 0.91
Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol (1998) 0.87
Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets. J Biol Chem (2013) 0.83
Mechanisms and models of immune tolerance breakdown in the ovary. Semin Reprod Med (2011) 0.80
A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease. Clin Exp Immunol (1998) 0.77
Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocr Connect (2014) 0.76
Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. Br J Cancer (2004) 0.76
Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium. J Clin Endocrinol Metab (2012) 0.76
A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency. Panminerva Med (2014) 0.75
Prevalence and clinical features of hypoadrenocorticism in Great Pyrenees dogs in a referred population: 11 cases. Can Vet J (2017) 0.75
High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res (1983) 9.94
Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet (2000) 3.17
Non-contiguous segments of the polyoma genome required in cis for DNA replication. J Mol Biol (1982) 3.03
Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia (1999) 2.81
The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia (1974) 2.69
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (1982) 2.58
Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest (2001) 2.35
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet (1995) 2.10
A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia (1994) 2.03
HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature (1983) 1.99
Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet (1996) 1.96
Genetic dissection of autoimmune type I diabetes in the BB rat. Nat Genet (1992) 1.87
Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension (2000) 1.87
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86
Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med (1993) 1.83
Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab (1999) 1.78
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
The pancreatic beta-cell recognition of insulin secretagogues. Effects of calcium and sodium on glucose metabolism and insulin release. Biochem J (1974) 1.76
The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia (2000) 1.74
Family cell lines available for research. Am J Hum Genet (1990) 1.72
Interferon expression in the pancreases of patients with type I diabetes. Diabetes (1995) 1.69
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab (1998) 1.68
Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry (2000) 1.67
Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab (1998) 1.63
Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med (1973) 1.62
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol (Oxf) (2000) 1.60
Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med (1978) 1.59
Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes. Diabetologia (2000) 1.53
Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods (1995) 1.51
Preparation and characterization of plasma membrane-enriched fractions from rat pancreatic islets. J Cell Biol (1976) 1.50
Ethidium-bromide-inhibited restriction endonucleases cleave one strand of circular DNA. Gene (1982) 1.49
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest (1996) 1.49
Influence of respiratory instability during neurocardiogenic presyncope on cerebrovascular and cardiovascular dynamics. Heart (2007) 1.49
Prognostic factors for the course of beta cell function in autoimmune diabetes. J Clin Endocrinol Metab (2000) 1.48
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care (1996) 1.46
Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab (1999) 1.45
Human cell lines from families available for diabetes research. Diabetologia (1991) 1.44
[Physiopathology of mitochondria. From Luft's disease to aging and diabetes]. Lakartidningen (1993) 1.42
Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia (1995) 1.42
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility. Clin Endocrinol (Oxf) (2001) 1.39
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. J Clin Endocrinol Metab (2004) 1.39
Adrenoleucodystrophy: dermatological findings and skin surface lipid study. Dermatology (1994) 1.39
Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia (1996) 1.38
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index. Diabetologia (1999) 1.37
The pancreatic beta-cell recognition of insulin secretogogues. Influence of neuraminidase treatment on the release of insulin and the islet content of insulin, sialic acid, and cyclic adenosine 3':5'-monophosphate. J Biol Chem (1974) 1.35
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest (1995) 1.33
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia (1988) 1.32
Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science (1984) 1.31
Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J (2003) 1.30
Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab (1994) 1.30
Human class II major histocompatibility antigen beta-chains are derived from at least three loci. Nature (1983) 1.29
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. J Clin Psychiatry (1999) 1.28
Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement. Diabetes (1981) 1.25
The pancreatic beta-cell recognition of insulin secretagogues: does cyclic AMP mediate the effect of glucose? Proc Natl Acad Sci U S A (1974) 1.24
Effects of whole-body vibration exercise on the endocrine system of healthy men. J Endocrinol Invest (2004) 1.23
[Isolated mouse islets as a model for studying insulin release]. Acta Diabetol Lat (1972) 1.21
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21
The pancreatic beta-cell recognition of insulin secretagogues. Comparisons of glucose with glyceraldehyde isomers and dihydroxyacetone. Arch Biochem Biophys (1974) 1.20
HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet (1993) 1.19
A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes (1981) 1.19
Immunology in diabetes: an update. Diabetes Metab Rev (1998) 1.18
Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol (2000) 1.18
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Diabetes Metab Res Rev (2005) 1.18
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care (1997) 1.17
Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest (1987) 1.17
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial. Diabet Med (2005) 1.17
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16
Iodoacetamide-induced sensitization of the pancreatic beta-cells to glucose stimulation. Biochem J (1973) 1.16
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation (1999) 1.15
Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat. Diabetologia (1984) 1.15
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab (2005) 1.15
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab (1996) 1.14